Abera Bioscience AB (FRA:8WK)
Germany · Delayed Price · Currency is EUR 0.6250
+0.0250 (4.17%)
At close: Jan 5, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of €11.7 million as of January 9, 2026. Its market cap has increased by 111.89% in one year.
Market Cap
11.70M
Enterprise Value
9.54M
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.63
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 11.47M to 11.70M, an increase of 2.05%. That is a compound annual growth rate of 0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 11.70M | 0.88% |
| Dec 30, 2025 | 11.60M | 92.03% |
| Dec 30, 2024 | 6.04M | -9.75% |
| Dec 29, 2023 | 6.69M | 20.37% |
| Dec 30, 2022 | 5.56M | -67.10% |
| Dec 30, 2021 | 16.90M | 47.38% |
| Feb 24, 2021 | 11.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |